Biomarker-driven targeted oral treatment strategy for bladder cancer

被引：0
|
作者：
Morera, Daley S.
Jordan, Andre
Lokeshwar, Vinata B.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1146
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BIOMARKER-DRIVEN TARGETED ORAL TREATMENT STRATEGY FOR BLADDER CANCER
    Schimmelpfennig, Daley
    Kemper, Michael W.
    Lokeshwar, Soum D.
    Jordan, Andre
    Lokeshwar, Vinata B.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E567 - E568
  • [2] Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
    Mishra, Prachi
    Laha, Dipranjan
    Grant, Robert
    Nilubol, Naris
    CANCERS, 2021, 13 (24)
  • [3] Development of a biomarker-driven patient selection strategy for AsiDNA treatment
    Jdey, Wael
    O'Brien, Donogh
    Tripelon, Richard
    Rochas, Severine
    Dutreix, Marie
    Bono, Francoise
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Biomarker-driven therapy in endometrial cancer
    Karpel, Hannah
    Slomovitz, Brian
    Coleman, Robert L.
    Pothuri, Bhavana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 343 - 350
  • [5] Biomarker-driven and molecular targeted therapies for colorectal cancers
    Schirripa, Marta
    Cohen, Stacey A.
    Battaglin, Francesca
    Lenz, Heinz-Josef
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 124 - 132
  • [6] Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers
    Harris, William R.
    Wong, Kit Man
    Saha, Supriya
    El Dika, Imane
    Abou-Alfa, Ghassan K.
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 116 - 123
  • [7] Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma
    Zhen, David B.
    Coveler, Andrew
    Zanon, Silvia
    Reni, Michele
    Chiorean, E. Gabriela
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 107 - 115
  • [8] BIOMARKER-DRIVEN PROGRAMS FOR LUNG CANCER SCREENING
    Massion, Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S6 - S6
  • [9] BIOMARKER-DRIVEN TREATMENT STRATEGIES FOR NON-SMALL-CELL LUNG CANCER
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 72 - 72
  • [10] A RISK SHARING MODEL FOR BIOMARKER-DRIVEN TREATMENT OF RARE SUBGROUPS OF CANCER PATIENTS
    Timmers, L.
    van Doorn, van Waalwijk S.
    Pisters, A.
    van Saase, L.
    Voest, E.
    VALUE IN HEALTH, 2019, 22 : S837 - S837
12345